جست‌وجوی استاد و پژوهشگر

Hiroaki Takahashiمشاهده پروفایل

استادیار

• Nuclear Medicine
• Abdominal Imaging
• Prostate Imaging
• +۵ مورد دیگر

Hiroaki Takahashi, M.D., Ph.D. is a Nuclear Medicine Specialist Radiologist at Mayo Clinic in Rochester, Minnesota. He serves as a member of the Department of Radiology with active participation in multiple tumor boards including the Adrenal Tumor Board, GYN Tumor Board, and as GU Imaging Liaison for the GU eTumor Board. His professional memberships include the Society of Nuclear Medicine and Molecular Imaging, Society of Abdominal Radiology, Radiological Society of North America, and American Board of Radiology. Dr. Takahashi's research focuses on nuclear medicine, abdominal imaging, and prostate imaging with a strong emphasis on artificial intelligence applications. His work spans multiple clinical areas including endometriosis detection, prostate cancer diagnosis, and upper urinary tract imaging. Recent publications demonstrate his innovative approach to developing MRI scoring systems, improving diagnostic accuracy through deep learning models, and analyzing anatomical structures for better clinical outcomes. Analysis of his recent publications (2024-2025) reveals a strong trend toward integrating artificial intelligence with traditional imaging techniques. His research shows particular emphasis on improving diagnostic accuracy in prostate imaging, developing standardized scoring systems for endometriosis, and applying anatomical knowledge to enhance imaging interpretation. The breadth of his work across multiple clinical specialties demonstrates his versatility as a radiologist and researcher. Certificate of Merit Radiological Society of North America (2024) Cum Laude RSNA (2023) RSNA Diagnosis Please Certificate of Recognition award (2023) Cum Laude RSNA (2022) Certificate of Merit RSNA (2022) Magna Cum Laude RSNA (2021) Itai Award Japan Radiological Society (2020) Certificate of Merit RSNA (2019) Dr. Takahashi maintains an active research program with numerous recent publications, suggesting strong grant support and institutional backing at Mayo Clinic. His collaborations span multiple departments including urology, gynecology, and oncology, indicating a well-integrated research program with clinical applications. His work on AI-assisted diagnostic models represents a growing area of funding interest in medical imaging. While no specific laboratory is mentioned, Dr. Takahashi's research involves collaboration with multiple imaging teams at Mayo Clinic, particularly in abdominal imaging, nuclear medicine, and AI applications. His work with deep learning models for endometriosis detection and prostate cancer diagnosis suggests involvement with computational imaging teams and access to advanced imaging technology at Mayo Clinic.

• Lipoprotein metabolism
• HDL (High-Density Lipoprotein) research
• Atherosclerosis
• +۷ مورد دیگر

Mary Sorci Thomas, PhD is a Professor with Tenure in the Department of Medicine, Division of Endocrinology at the Medical College of Wisconsin and in the Department of Pathology Section on Lipid Sciences at Wake Forest University School of Medicine. She serves as Associate Director of the Cardiovascular Center and Associate Program Director of the CVC T32 Training Program at MCW. Dr. Sorci Thomas is an internationally recognized expert in lipoprotein metabolism and HDL research with over 30 years of continuous NIH funding. Dr. Sorci Thomas's research program focuses on the structural and functional properties of apolipoprotein A-I and HDL, with particular emphasis on how these relate to cholesterol transport, inflammation, and atherosclerosis. Her work has provided fundamental insights into the mechanisms of HDL biogenesis, the role of specific apolipoprotein domains in LCAT activation, and the relationship between HDL function and immune regulation. Her laboratory employs a multidisciplinary approach combining protein chemistry, molecular biology, cell culture, and animal models to investigate these processes. Analysis of Dr. Sorci Thomas's recent publications reveals a continued focus on HDL structure-function relationships, with increasing attention to the connections between lipid metabolism, inflammation, and vascular biology. Her work spans basic mechanistic studies of apolipoprotein structure to translational investigations of HDL function in disease processes, demonstrating a consistent trajectory of high-impact research in lipoprotein biology. Established Investigator, American Heart Association (1994-1999) Women's Mentoring Award, American Heart Association (2002) Special Recognition Award, Arteriosclerosis, Thrombosis and Vascular Biology Council (2002) Chair, Gordon Conference on Lipoprotein Metabolism (2006) Chair, Kern Aspen Lipid Meeting (2010-Present) Co-Chair, Atherosclerosis, Thrombosis and Vascular Biology Council of AHA (2016-2022) Dr. Sorci Thomas has mentored numerous students, postdocs, and junior faculty throughout her career. As Associate Program Director of the CVC T32 Training Program at MCW, she continues to play an active role in training the next generation of cardiovascular researchers. Her mentorship extends beyond her own laboratory through her leadership roles in national organizations and scientific review panels.

• Pediatric Hematology/Oncology
• Leukemia/Lymphoma
• Vascular Anomalies
• +۴ مورد دیگر

Dr. Richard L. Tower is a Professor of Pediatric Hematology/Oncology/BMT at the Medical College of Wisconsin (MCW), where he also serves as Interim Medical Director of Pediatric Hematology/Oncology/BMT (2024-Present). With over 15 years of academic experience, he has progressed from Assistant Professor (2007-2015) to Associate Professor (2015-2022) to his current full Professor position. Dr. Tower holds multiple leadership roles including Director of the Fellowship Program (2012-Present) and Co-Director of Fellowship Education (2014-Present) at MCW. He is actively involved in national organizations as a member of the Board of Trustees for the American Society of Pediatric Hematology/Oncology (ASPHO) and serves on the Accreditation Appeals Panel for Pediatric Hematology/Oncology at the ACGME. Dr. Tower's research focuses on pediatric leukemia/lymphoma, vascular anomalies, lymphatic system disorders, and medical education in hematology-oncology. His recent work includes multiple chapters in Nelson Textbook of Pediatrics on lymphatic system anatomy and disorders (2024), research on targeted treatments for vascular anomalies (2021), and development of communication skills simulation training for fellowship education (2025). His publications demonstrate expertise across clinical hematology-oncology, medical education, and rare disease management, with work appearing in high-impact journals including Journal of Pediatric Hematology and Oncology, British Journal of Dermatology, and JAMA Dermatology. Dr. Tower has received numerous teaching awards including being named to 'Best Doctors in America' for five consecutive periods (2013-2022) and the 'Expert Teacher' award from Pediatrics (2016). His leadership extends to national medical education initiatives where he has contributed to the development of Entrustable Professional Activities for Pediatric Hematology-Oncology and served on ACGME committees developing milestones for fellowship training. He has mentored over 20 fellows since 2007 and continues to shape the next generation of pediatric hematology-oncology specialists through his educational leadership and research mentorship.

Vasso Anagnostopoulouمشاهده پروفایل

پژوهشگر ارشد

• Medical Statistics
• Clinical Trials Methodology
• Global Health
• +۵ مورد دیگر

Dr. Vasso Anagnostopoulou is a Senior Research Fellow in Medical Statistics at the Brighton and Sussex Medical School (BSMS), working within the Department of Primary Care & Public Health. She is actively affiliated with multiple research units including the NIHR Global Health Research Unit for Neglected Tropical Diseases, the NIHR Social Sciences for Severe Stigmatising Skin Conditions (5S) Foundation, and the Brighton & Sussex Clinical Trials Unit where she serves as statistician for the REDUCe 2 and Chelsea II trials. Her career spans both pure mathematics and applied medical statistics, reflecting a unique interdisciplinary trajectory. Dr. Anagnostopoulou's educational background demonstrates her interdisciplinary journey: BSc (Hons) and MSc in Mathematics from the University of Warwick, PhD in Mathematics (Dynamical Systems) from Queen Mary University of London, followed by postdoctoral positions at TU Dresden, Imperial College London (as a Marie Curie Intra-European Fellow), and Queen Mary University of London. In 2023, she completed an MSc in Medical Statistics from the London School of Hygiene and Tropical Medicine, marking her transition to applied medical research. Her research spans two distinct but complementary domains: mathematical theory (particularly dynamical systems) and medical statistics applied to global health. She focuses on neglected tropical diseases (especially podoconiosis), with significant work in hepatology (cirrhosis management) and cardiology (thoracic aortic aneurysms). Her recent publications demonstrate a clear shift from pure mathematics to applied medical research, with an emphasis on implementation science, clinical trials methodology, and health outcomes in global health contexts. She has co-authored numerous high-impact studies in journals like BMC Medicine and PLoS Neglected Tropical Diseases. Dr. Anagnostopoulou actively contributes to major clinical trials and implementation research projects, particularly in Ethiopia. Her work addresses critical gaps in healthcare for neglected populations, focusing on stigma reduction, community interventions, and cost-effective care packages. As a statistician on multiple NIHR-funded projects, she plays a crucial role in designing robust studies and analyzing complex health data from diverse global settings. She serves as a joint supervisor for research projects, including 'Assessing the Health and Economic Burden of podoconiosis in Rwanda,' and is involved in mentoring the next generation of global health researchers. Her dual expertise in advanced mathematics and medical statistics positions her as a valuable collaborator who can bridge theoretical rigor with practical healthcare applications in resource-limited settings.

• Health Economics
• Economic Evaluation
• Neglected Tropical Diseases
• +۶ مورد دیگر

Dr. Natalia Ivashikina is a Reader in Health Economics at the Department of Global Health and Infection, Brighton and Sussex Medical School, University of Sussex. She joined the department in December 2017 and has established herself as a leading researcher in economic evaluation of healthcare interventions, particularly for neglected tropical diseases in low- and middle-income countries. Dr. Ivashikina completed her PhD at Moscow State University in 1996, followed by a Royal Society Fellowship in the UK (1997-1998). She then conducted research at Würzburg University, Germany (1999-2005), and completed an MSc in Health and Social Care Research at Sheffield University in 2011. Prior to joining Brighton and Sussex Medical School, she worked at Bangor University (2008-2013) and Queen Mary University of London (2013-2017). Her research focuses on economic evaluation methodologies and their application to neglected tropical diseases (podoconiosis, mycetoma, and scabies), HIV, non-medical prescribing, and neonatal care. Dr. Ivashikina's work spans all aspects of economic evaluations, from systematic literature review to statistical analysis and economic modeling. She has established extensive international collaborations with institutions across Africa and Europe. Her recent publications (2020-2025) demonstrate consistent output in high-impact journals, with a clear focus on cost-effectiveness analyses of interventions for neglected diseases and healthcare delivery improvements in diverse settings. Dr. Ivashikina has secured substantial research funding from NIHR, European Commission, and other sources for projects including the NIHR Brighton and Sussex Centre for Global Health Research (2021-2026), a study on self-neglect (2022-2024), and the RISEinFAMILY neonatal care project (2021-2025). Her research has significant policy implications, with several studies referenced in policy documents and picked up by news outlets. She leads the postgraduate module on Economic Evaluation in Health Care and supervises undergraduate medical students, MSc students, and PhD candidates. Her teaching emphasizes practical applications of health economics in global health contexts, and she has developed curriculum for both undergraduate and postgraduate programs throughout her career.

• Global Mental Health
• Neglected Tropical Diseases
• Stigma Reduction
• +۵ مورد دیگر

Dr. Maya Semrau is a Senior Research Fellow in Implementation Research at Brighton and Sussex Medical School (BSMS), University of Sussex, specializing in global mental health within Neglected Tropical Disease contexts. Her work integrates physical health, mental health, and psychosocial care for people affected by podoconiosis, lymphatic filariasis, and leprosy in Ethiopia, with strong emphasis on stigma reduction and humanitarian emergency response. Her educational background includes: PhD, Institute of Psychiatry, Psychology and Neuroscience (IoPPN), King's College London (with WHO) MSc in Mental Health Service and Population Research, IoPPN, King's College London MSc in Experimental Psychology, University of Sussex BSc Honours in Human Sciences, University of Sussex Dr. Semrau's research centers on implementation science to address mental health needs in resource-limited settings, particularly through the development of the HESPER Scale for humanitarian emergencies and integration of mental health into NTD programs. Her work consistently emphasizes community involvement, capacity building, and evidence-based policy development across multiple international projects. Her publication record (2011-2019) reveals persistent focus on mental health systems strengthening in LMICs, stigma reduction, and physical-mental health integration for NTD-affected populations. She employs diverse methodologies including scale development, cross-sectional studies, systematic reviews, and implementation trials to address real-world health challenges. Dr. Semrau actively supervises PhD and MSc students at BSMS and teaches on the MSc in Global Health program. She currently leads the EnDPoINT Consortium and IMPRESS project funded by the NIHR Global Health Research Unit on NTDs, with additional involvement in WHO guideline development and the NTD NGO Network's Mental Wellbeing and Stigma Working Group. Her collaborative work spans the Emerald programme across six LMICs, the INDIGO Partnership in five countries, and multiple WHO initiatives, demonstrating extensive international engagement in mental health and NTD research through coordinated multicountry efforts.

Heather Himburgمشاهده پروفایل

استاد

• Radiation Biology
• Cancer Stem Cell Biology
• Hematopoiesis
• +۲ مورد دیگر

Heather Himburg, PhD, serves as Professor in the Department of Radiation Oncology at the Medical College of Wisconsin (MCW), where her research focuses on radiation biology and therapeutic development for radiation injury mitigation. Her work bridges translational science and clinical applications in radiation oncology. Education: PhD in Biomedical Engineering, Duke University, 2005 MS in Biomedical Engineering, Ohio State University, 2001 BS in Physics, Miami University, 1998 Research Focus: Dr. Himburg's laboratory investigates acute and delayed radiation effects on multiple organ systems, with specialization in vascular injury mechanisms and bone marrow microenvironment dynamics. Her team develops countermeasures for hematopoietic acute radiation syndrome and studies cancer stem cell biology to improve radiation therapy safety. Current projects target radioprotective therapeutics for bone marrow, heart, lung, and kidney tissues using preclinical models established by MCW emeritus researchers Meetha Medhora and John Moulder. Publication Analysis: Her 2024-2025 publications reveal dominant themes in head and neck cancer therapeutics, radiation-induced organ toxicity, and immune modulation. Key trends include molecular radiosensitization strategies (CXCL12 pathways), advanced imaging for treatment response monitoring, and novel countermeasures for radiation syndromes. The work consistently integrates translational approaches from in vitro models to rodent studies, emphasizing clinical applicability in radiation oncology. Laboratory Structure: The Himburg Laboratory (MFRC 4072/4004 lab, 4076 office) operates as a collaborative hub with Brian Fish directing the Precision Irradiation Core. The team comprises research scientists, technologists, and coordinators specializing in vascular biology, stem cell assays, and radiation countermeasure development, supporting MCW's radiation oncology research infrastructure through the ROCKET Program.

Isabelle Brunetمشاهده پروفایل

پژوهشگر

• Neurovascular Interactions
• Neuroscience
• Vascular Biology
• +۳ مورد دیگر

Isabelle Brunet is a leading neuroscientist and vascular biologist holding a permanent Inserm research position (ranked 1st) at the Interdisciplinary Center for Research in Biology (CIRB) of the Collège de France in Paris. She directs an 8-member research team investigating neurovascular interactions in development and disease using transgenic mouse/fish models, molecular approaches, and 3D-imaging techniques. Her educational foundation includes a PhD in neuroscience under Alain Prochiantz and Christine Holt focusing on axon guidance in the visual system, followed by postdoctoral training with Anne Eichmann in vascular biology and angiogenesis. This dual expertise enables her unique perspective on neurovascular crosstalk. Brunet's research centers on deciphering how neuronal and vascular systems interact during development and in pathological conditions. Her work explores guidance mechanisms (e.g., Ephrin-A4/EphA4, Netrin-1), arterial innervation dynamics, and lymphatic-vascular interactions, with significant implications for understanding chemotherapy-induced neuropathies and vascular disorders. She employs cutting-edge methodologies including tissue-clearing 3D imaging and functional assays to visualize neurovascular interfaces at cellular resolution. Analysis of her 2014-2022 publications reveals consistent advancement in understanding neurovascular patterning, with particular emphasis on sympathetic innervation of arteries, perivascular macrophage heterogeneity, and Schwann cell-vascular interactions. Her work bridges fundamental developmental biology with translational applications in neuropathic pain and vascular pathologies. Brunet actively contributes to scientific governance through evaluations for Inserm CSS, HCERES, Doctoral Schools, and journal/grant reviews. Her leadership extends to mentoring her research team and disseminating findings through publications and presentations. The Molecular Control of Neurovascular Development laboratory at CIRB operates as a dynamic interdisciplinary hub where neuroscientists, vascular biologists, and imaging specialists collaborate using transgenic models and advanced microscopy to unravel neurovascular communication mechanisms. Current projects focus on functional consequences of neurovascular mispatterning in disease contexts.

Alpaslan Tasdoganمشاهده پروفایل

استاد

• Cancer Metabolism
• Tumor Metastasis
• Stem Cell Biology
• +۴ مورد دیگر

Professor Alpaslan Tasdogan leads the Tumor Metabolism Group at the Institute for Tumor Metabolism, Clinic and Polyclinic for Dermatology, Allergology and Venereology at University Hospital Essen, which is part of the University of Duisburg-Essen's Faculty of Medicine. His research focuses on cancer cell metabolism , particularly the metabolic changes that occur during tumor metastasis and in stem cells. The Tumor Metabolism Group investigates how cancer cells adapt their metabolism to survive the complex process of metastasis, with special attention to hematopoietic stem cells where metabolic processes are tightly regulated during regeneration. The group employs modern mass spectrometry techniques and stable isotope-labeled nutrients to precisely analyze cellular metabolism and metabolic flux within cells. Their research spans multiple cancer types with emphasis on melanoma and stem cell metabolism. Analysis of Dr. Tasdogan's publication record reveals a strong focus on tumor metabolism , metastasis mechanisms , and stem cell biology . His recent work spans diverse areas including purine synthesis in tumors, intestinal stem cell regulation via polyamines, and lymphatic protection of metastasizing melanoma cells from ferroptosis. His research demonstrates significant interdisciplinary collaboration, with publications appearing in top journals including Nature , Cell , and Science , often in collaboration with prominent researchers like Morrison SJ and Schadendorf D. The Tumor Metabolism Group's ultimate goal is to gain significant new insights into metastasis to identify metabolic adaptations, with plans to apply their metabolic testing methods to other cancer types and stem cells to examine the transferability of their findings.

• Infectious Diseases
• Tropical Medicine
• Malaria
• +۴ مورد دیگر

Prof. Dr. Achim Hörauf serves as Professor at the University of Bonn's Faculty of Medicine and holds dual leadership roles as Deputy Partner Site Speaker for the Bonn-Köln site and Deputy Coordinator for Malaria and Neglected Tropical Diseases at the German Center for Infection Research (DZIF). His research focuses on developing novel antibiotics targeting Wolbachia endosymbionts in filarial parasites, with significant work on Corallopyronin A for river blindness treatment. Hörauf's research spans Infectious Diseases, Tropical Medicine, and Antibiotics Development, emphasizing macrofilaricidal agents against Onchocerca volvulus. His team investigates immune responses in filariasis, pneumococcal vaccination in immunocompromised patients, and lymphatic pathology mechanisms. Key contributions include advancing Corallopyronin A through preclinical development and establishing diagnostic protocols for onchocerciasis vector surveillance. Analysis of his 15 most recent publications (2022-2024) reveals three dominant research thrusts: 1) Anti-Wolbachial drug development (Corallopyronin A, Muraymycin D2), 2) Immunological profiling of filarial infections (T-cell exhaustion, IgG glycosylation patterns), and 3) Epidemiological studies of neglected tropical diseases (lymphedema microbiology, epilepsy comorbidity). This work bridges basic microbiology with clinical applications for river blindness and lymphatic filariasis. While specific advisees and grant details aren't provided in source materials, Hörauf's DZIF leadership roles indicate active mentorship within the Bonn-Köln research consortium. His work receives institutional support through University Hospital Bonn's tropical medicine infrastructure. Hörauf directs research teams at the DZIF Partner Site Bonn-Köln, collaborating with University Hospital Bonn's tropical medicine division. His laboratory focuses on Wolbachia-targeted therapies and immunological diagnostics for filarial diseases, maintaining active projects on macrofilaricidal drug development and field epidemiology in endemic regions.

Eva Liebauمشاهده پروفایل

استاد

• Glutathione metabolism
• Oxidative stress response
• Parasitic nematodes
• +۵ مورد دیگر

Prof. Dr. Eva Liebau is a Professor and Group Leader at the Institute for Integrative Cell Biology and Physiology, University of Münster, Germany, specializing in Molecular Physiology. She leads an active research group investigating glutathione metabolism, oxidative stress response, and parasitic nematodes, with significant involvement in the SãMBio German-Brazilian double degree program with the University of São Paulo. Her research focuses on the molecular mechanisms of genetic adaptation to xenobiotic compounds and oxidative stressors, using Caenorhabditis elegans as a model organism. Her work spans environmental stress response, thiol-based redox signaling, glutathione-related enzymes, regulation of translation, and the secretome of parasitic nematodes. She has made significant contributions to understanding the UFM1 cascade, a posttranslational modification system highly conserved in multicellular organisms. Prof. Liebau's recent publications reveal a strong trend toward anthelmintic drug discovery using natural compounds and plant extracts, with particular emphasis on understanding the mechanisms of action against parasitic nematodes. Her work bridges basic molecular research with applied parasitology, contributing to both fundamental understanding of stress responses and potential therapeutic applications. She actively supervises PhD and MSc students including Emma Schröder and Luka Ressmann, and collaborates extensively with international partners including the Institute of Biomedical Sciences at the University of São Paulo, the Institute of Pharmaceutical Biology and Phytochemistry at the University of Münster, and the Redox Homeostasis Group at the Institute of Biomedicine of Seville. Prof. Liebau is affiliated with multiple research networks including Cells in Motion, CRC 1009 (Breaking Barriers), CRC 1348 (Dynamic Cellular Interfaces), CRC 1459 (Intelligent Matter), and CRC 944 (Physiology and Dynamics of Cellular Microcompartments), and participates in several PhD programs including CiM-IMPRS, IRTG Graduate School, and SP BioSciences.

• Pediatric Cardiology
• Echocardiography
• Cardiac Mechanics
• +۴ مورد دیگر

Murat Deveci is an Associate Professor of Pediatric Cardiology at Kocaeli University School of Medicine, with extensive clinical and research activities spanning pediatric cardiovascular diseases, echocardiography, and cardiac complications in systemic disorders. His work integrates clinical practice with advanced diagnostic techniques including speckle tracking echocardiography. His primary research interests focus on pediatric cardiac mechanics , Kawasaki disease complications , cardiovascular risk in chronic kidney disease , and early markers of atherosclerosis in hypertensive children . He utilizes advanced echocardiographic techniques to detect subclinical cardiac involvement in conditions like celiac disease, lupus, and obesity. Analysis of his 15 most recent publications reveals strong emphasis on translational research connecting basic cardiac mechanics with clinical outcomes , particularly in vulnerable pediatric populations including cancer survivors, CKD patients, and those with autoimmune disorders. His work frequently addresses diagnostic challenges in rare cardiac pathologies. Temel Ekokardiyografi Kursu Birinciligi (Basic Echocardiography Course First Place), 2012 Sahra Sihhiye Okulu 306. Dönem Astegmen Kursu Ikinciligi (Desert Sanitary School Cadet Course Second Place), 2005 Deveci actively mentors numerous junior researchers including Babaoglu, Kayabey Colak, and Tugral, with collaborative work extending to cardiovascular complications in genetic syndromes and inflammatory conditions. His research often involves multicenter collaborations addressing critical gaps in pediatric cardiovascular risk stratification.

• Physical Medicine and Rehabilitation
• Osteoporosis
• Joint Hypermobility and Ehlers-Danlos Syndrome
• +۷ مورد دیگر

Derya DEMİRBAĞ KABAYEL is a Professor at Trakya University Medical Faculty, Department of Physical Medicine and Rehabilitation since 2015. She holds a Doctoral degree obtained in 2003 and has established herself as a prominent researcher in rehabilitation medicine with a focus on multiple specialized areas. Her primary research interests include: Physical Medicine and Rehabilitation protocols Osteoporosis and bone mineral density assessment Joint hypermobility and Ehlers-Danlos Syndrome Parkinson's Disease rehabilitation Pulmonary rehabilitation, particularly related to post-COVID-19 recovery Cardiac rehabilitation and exercise physiology Her publication record demonstrates expertise in developing rehabilitation guidelines, particularly for post-COVID-19 patients, with numerous articles addressing pulmonary rehabilitation principles for acute, subacute, and long-term recovery phases. Her work on Parkinson's rehabilitation compares different exercise modalities including cycle ergometry versus body weight-supported treadmill training. Her research on joint hypermobility spans genetic factors, cardiovascular associations like mitral valve prolapse, and potential biomarkers for Ehlers-Danlos Syndromes. She has also contributed significantly to understanding the relationship between exercise capacity and psychological factors in cardiac rehabilitation. Professor Kabayel has served as a referee for multiple prestigious journals including Turkish Journal of Physical Medicine and Rehabilitation, Archives of Rheumatology, and Balkan Medical Journal. She has participated extensively in national and international conferences, often as a speaker, session chair, or course instructor on topics ranging from lymphedema management to cardiac rehabilitation for spinal cord injury patients. She has advised doctoral dissertations focusing on Parkinson's disease rehabilitation approaches and has participated in various research projects examining multifidus muscle relationships with postural sway, Parkinson's rehabilitation, and gene expression in joint hypermobility cases.

Michael Bachmann Nielsenمشاهده پروفایل

استاد بالینی

• Radiology
• Medical Imaging
• Artificial Intelligence Applications
• +۳ مورد دیگر

Michael Bachmann Nielsen, DMSc, PhD, serves as a Clinical Professor in the Department of Clinical Medicine at the University of Copenhagen's Faculty of Health and Medical Sciences, maintaining dual affiliations with the Radiology department and Capital Region of Denmark (Region Hovedstaden) at Blegdamsvej addresses in Copenhagen. His active clinical-academic role bridges medical practice and research innovation. His research program focuses on: AI-driven optimization of medical imaging workflows Advanced ultrasound techniques including super-resolution vascular imaging Clinical applications in neuroimaging, oncology, and pediatric diagnostics Machine learning for radiology report analysis and protocol adaptation Recent publications demonstrate significant contributions to MRI protocol refinement, tumor volume delineation, and contrast-free microvascular imaging. His work consistently appears in high-impact journals like European Journal of Radiology and Scientific Reports, emphasizing practical clinical translation of imaging technologies through cross-disciplinary collaboration. Nielsen's extensive publication record (291 outputs) reflects leadership in adapting artificial intelligence to radiology practice, with particular emphasis on workflow efficiency and diagnostic accuracy across diverse clinical scenarios.

John A. Lincolnمشاهده پروفایل

استاد

• Multiple Sclerosis
• Neuroimmunology
• Neurodegeneration
• +۷ مورد دیگر

John A. Lincoln, MD, PhD is a Professor of Neurology at The University of Texas Health Science Center at Houston (UTHealth), where he serves as Director of the MRI Analysis Center and Co-Director of the Neurology Residency Program. He joined the Multiple Sclerosis research group at UTHealth in 2011 after previously serving on the faculty at the University of Medicine and Dentistry of New Jersey (UMDNJ) from 2008-2011. Dr. Lincoln earned his Bachelor of Science in Genetics from Texas A&M University in 1992, followed by a Master's in Microbiology and PhD in Immunology from Texas Tech University. He completed his medical degree at Texas Tech University Health Sciences Center in 2002, followed by a Neurology residency at UT Health Science Center at Houston and a Neuroimmunology fellowship at UMDNJ. His research focuses on neurodegenerative processes in multiple sclerosis, with particular emphasis on glymphatic system dysfunction, cerebrovascular reactivity, spinal cord evaluation, and bladder-related neurological complications. Recent publications demonstrate his integration of advanced MRI techniques with machine learning approaches to predict disease severity and understand MS pathology. Analysis of his publication record from 2008-2024 reveals a consistent research trajectory focused on MS mechanisms and clinical manifestations, with increasing emphasis on neuroimaging biomarkers and computational approaches in recent years. His work spans clinical neurology, neuroimmaging, immunology, and rehabilitation aspects of MS. As Director of the MRI Analysis Center, Dr. Lincoln oversees advanced neuroimaging research and clinical applications. His leadership in the Neurology Residency Program demonstrates his commitment to training the next generation of neurologists specializing in complex neurological disorders. Dr. Lincoln's clinical expertise includes diagnosing and managing multiple sclerosis and immune-mediated neurological disorders, with special attention to neurological complications such as bladder dysfunction and trigeminal neuralgia in MS patients. His multidisciplinary approach bridges basic science discoveries with clinical applications to improve patient outcomes.